Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status
Standardized uptake value
DOI:
10.1371/journal.pone.0158307
Publication Date:
2016-06-23T17:43:36Z
AUTHORS (4)
ABSTRACT
The study objective was to retrospectively analyze the metabolic variables derived from 18 F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) as predictors of progression-free survival (PFS) and overall (OS) in advanced lung adenocarcinoma stratified by epidermal growth factor receptor (EGFR) mutation status. A total 176 patients (91, EGFR mutation; 85, wild-type EGFR) who underwent 18F-FDG PET/CT before treatment were enrolled. main PET/CT-derived variables: primary tumor maximum standardized uptake value (SUVmaxT), lesion glycolysis (TLGT), SUVmax all selected lesions whole body determined using Response Evaluation Criteria In Solid Tumors (RECIST) 1.1 criteria (SUVmaxWBR), whole-body TLG RECIST (TLGWBR) measured. Survival analysis regarding TLGWBR, other factors status, evaluated. results indicated that high TLGWBR (≥259.85), wild-type, serum LDH independent worse PFS OS with adenocarcinoma. Among EGFR, only retained significance an predictor both OS. mutation, level OS, (≥259.85) but not conclusion, is a promising parameter for prognostic stratification status; however, it cannot be used further stratify risk mutation. Further prospective studies are needed validate our findings.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (34)
CITATIONS (12)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....